title: Inhibition of apurinic/apyrimidinic endonuclease I's redox activity revisited.
abstract: The essential base excision repair protein, apurinic/apyrimidinic endonuclease 1 (APE1), plays an important role in redox regulation in cells and is currently targeted for the development of cancer therapeutics. One compound that binds APE1 directly is (E)-3-[2-(5,6-dimethoxy-3-methyl-1,4-benzoquinonyl)]-2-nonylpropenoic acid (E3330). Here, we revisit the mechanism by which this negatively charged compound interacts with APE1 and inhibits its redox activity. At high concentrations (millimolar), E3330 interacts with two regions in the endonuclease active site of APE1, as mapped by hydrogen-deuterium exchange mass spectrometry. However, this interaction lowers the melting temperature of APE1, which is consistent with a loss of structure in APE1, as measured by both differential scanning fluorimetry and circular dichroism. These results are consistent with other findings that E3330 concentrations of >100 μM are required to inhibit APE1's endonuclease activity. To determine the role of E3330's negatively charged carboxylate in redox inhibition, we converted the carboxylate to an amide by synthesizing (E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylene]-N-methoxy-undecanamide (E3330-amide), a novel uncharged derivative. E3330-amide has no effect on the melting temperature of APE1, suggesting that it does not interact with the fully folded protein. However, E3330-amide inhibits APE1's redox activity in in vitro electrophoretic mobility shift redox and cell-based transactivation assays, producing IC(50) values (8.5 and 7 μM) lower than those produced with E3330 (20 and 55 μM, respectively). Thus, E3330's negatively charged carboxylate is not required for redox inhibition. Collectively, our results provide additional support for a mechanism of redox inhibition involving interaction of E3330 or E3330-amide with partially unfolded APE1.
authors.affiliation: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
authors.forename: Jun
authors.initials: J
authors.lastname: Zhang
authors.forename: Meihua
authors.initials: M
authors.lastname: Luo
authors.forename: Daniela
authors.initials: D
authors.lastname: Marasco
authors.forename: Derek
authors.initials: D
authors.lastname: Logsdon
authors.forename: Kaice A
authors.initials: KA
authors.lastname: LaFavers
authors.forename: Qiujia
authors.initials: Q
authors.lastname: Chen
authors.forename: April
authors.initials: A
authors.lastname: Reed
authors.forename: Mark R
authors.initials: MR
authors.lastname: Kelley
authors.forename: Michael L
authors.initials: ML
authors.lastname: Gross
authors.forename: Millie M
authors.initials: MM
authors.lastname: Georgiadis
mesh_terms: D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D005470:Fluorometry; D013058:Mass Spectrometry; D008958:Models, Molecular; D010084:Oxidation-Reduction; D015533:Transcriptional Activation
chemical_list: D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase